These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 3719082)

  • 1. Models for the subunit arrangement in soluble and aggregated plasma fibronectin.
    Hörmann H; Richter H
    Biopolymers; 1986 May; 25(5):947-58. PubMed ID: 3719082
    [No Abstract]   [Full Text] [Related]  

  • 2. Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins.
    Sekiguchi K; Hakomori S
    J Biol Chem; 1983 Mar; 258(6):3967-73. PubMed ID: 6833239
    [No Abstract]   [Full Text] [Related]  

  • 3. Arrangement of attachment-promoting, self-association, and heparin-binding sites in horse serum fibronectin.
    Ehrismann R; Roth DE; Eppenberger HM; Turner DC
    J Biol Chem; 1982 Jul; 257(13):7381-7. PubMed ID: 7085631
    [No Abstract]   [Full Text] [Related]  

  • 4. Domain structure of hamster plasma fibronectin. Isolation and characterization of four functionally distinct domains and their unequal distribution between two subunit polypeptides.
    Sekiguchi K; Fukuda M; Hakomori S
    J Biol Chem; 1981 Jun; 256(12):6452-62. PubMed ID: 7240218
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of two fibrin-binding domains in plasma fibronectin and unequal distribution of these domains in two different subunits: a preliminary note.
    Sekiguchi K; Hakomori S
    Biochem Biophys Res Commun; 1980 Nov; 97(2):709-15. PubMed ID: 7470122
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complex-formation between myeloperoxidase and fibronectin and its modulation by fibronectin ligands].
    Iankovskiĭ OIu; Iablunovskaia IA; Kokriakov VN; Aleshina GM; Khilazhetdinova LR; Govorova NIu; Podsukhina GM; Gavrilova IuV; Vakhrushev AV; Leonova NV
    Vopr Med Khim; 1996; 42(2):137-40. PubMed ID: 9148599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of fibrin solubility by plasma fibronectin.
    Kaplan JE; Snedeker PW
    J Lab Clin Med; 1980 Dec; 96(6):1054-61. PubMed ID: 7430761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of plasma fibronectin.
    Clemmensen I
    Haematologia (Budap); 1984; 17(1):101-6. PubMed ID: 6373513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological arrangement of the major structural features of fibronectin.
    Wagner DD; Hynes RO
    J Biol Chem; 1980 May; 255(9):4304-12. PubMed ID: 7372678
    [No Abstract]   [Full Text] [Related]  

  • 10. Solution structure of human plasma fibronectin under different solvent conditions. Fluorescence energy transfer, circular dichroism and light-scattering studies.
    Lai CS; Wolff CE; Novello D; Griffone L; Cuniberti C; Molina F; Rocco M
    J Mol Biol; 1993 Mar; 230(2):625-40. PubMed ID: 8464068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near ultraviolet circular dichroism spectroscopy of plasma fibronectin and fibronectin fragments.
    Tooney NM; Amrani DL; Homandberg GA; McDonald JA; Mosesson MW
    Biochem Biophys Res Commun; 1982 Oct; 108(3):1085-91. PubMed ID: 6924856
    [No Abstract]   [Full Text] [Related]  

  • 12. Location of the binding site in subcomponent C1q for plasma fibronectin.
    Reid KB; Edmondson J
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():11-7. PubMed ID: 6610277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of fibronectin with monoclonal antibodies.
    Atherton BT; Taylor DM; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(2):153-61. PubMed ID: 7321057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subunit interactions in human plasma fibronectin.
    Robinson RM; Hermans J
    Biochem Biophys Res Commun; 1984 Nov; 124(3):718-25. PubMed ID: 6239619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of plasma fibronectin to Candida albicans occurs through the cell binding domain.
    Penn C; Klotz SA
    Microb Pathog; 1994 Dec; 17(6):387-93. PubMed ID: 7752880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An axial periodic fibrillar arrangement of antigenic determinants for fibronectin and procollagen on ascorbate treated human fibroblasts.
    Furcht LT; Wendelschafer-Crabb G; Mosher DF; Foidart JM
    J Supramol Struct; 1980; 13(1):15-33. PubMed ID: 6160320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease.
    Schnog JB; Mac Gillavry MR; Rojer RA; Meijers JC; Fijnheer R; ten Cate H; Brandjes DP; Duits AJ
    Am J Hematol; 2002 Sep; 71(1):53-5. PubMed ID: 12221677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma fibronectin: three steps to purification and stability.
    Poulouin L; Gallet O; Rouahi M; Imhoff JM
    Protein Expr Purif; 1999 Oct; 17(1):146-52. PubMed ID: 10497080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of an immunoglobulin-like serum protein possessing a high affinity for collagen].
    Zlatopol'skiĭ AD; Zykova TA; Mazurov VI
    Biokhimiia; 1983 Nov; 48(11):1897-905. PubMed ID: 6661462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topological arrangement of four functionally distinct domains in hamster plasma fibronectin: a study with combination of S-cyanylation and limited proteolysis.
    Sekiguchi K; Hakomori S
    Biochemistry; 1983 Mar; 22(6):1415-22. PubMed ID: 6838861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.